FDA Warning Letter — Baxalta Belgium Manufacturing SA

Case 88024 — FEI 3002806503

The FDA took a Warning Letter action against Baxalta Belgium Manufacturing SA on Jan 15, 2010 (Lessines, Belgium). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Baxalta Belgium Manufacturing SA
Date
Jan 15, 2010
Fiscal Year
2010
Product Type
Biologics
Center
CBER
Location
Lessines (Belgium)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.